India Maintains Ample Anti-TB Drug Supply, Says Govt

National TB Elimination Programme Ensures Consistent Anti-TB Drug Availability

India’s National TB Elimination Programme (NTEP) has successfully maintained a regular supply of anti-tuberculosis drugs across all states and union territories, ensuring no shortage in the country.

DELHI – India’s fight against tuberculosis (TB) is bolstered by the consistent availability of anti-TB drugs nationwide, thanks to the National TB Elimination Programme (NTEP).

Throughout the year, NTEP has ensured a steady supply of these crucial medications to every state and union territory.

Regular assessments are conducted to monitor the stock positions of anti-TB drugs, from central warehouses to peripheral health institutes.

This systematic approach ensures that any potential shortages are promptly addressed.

In addition to the central supply, states and union territories have access to resources for local procurement of anti-TB drugs.

This provision allows for the quick acquisition of limited quantities of drugs to meet any emergent requirements.

The proactive measures taken by NTEP underline India’s commitment to eliminating tuberculosis.

The availability of these drugs at various levels of healthcare institutions signifies a robust public health response.

The strategy of combining central supply with the provision for local procurement ensures flexibility and responsiveness in the healthcare system.